- This event has passed.
October 29, 2015 @ 8:00 am - 1:00 pm
Mission Possible: Non-traditional Avenues to Funding Your Start-Up
Mark your calendar and plan to attend BioNJ’s Entrepreneurship Program, Thursday, October 29, hosted by Rutgers University. Join BioNJ for this interactive event that will discuss funding opportunities from the NJ Health Foundation and the U.S.-Israel R&D Fund (BIRD Foundation), as well as new vehicles being offered from big biopharmas for start-ups and early stage companies.
You’ll hear from decision makers at these organizations about mission-driven investments in early stage companies and learn firsthand from recipients on how they successfully competed for funding. Click here for the program agenda.
The half-day event from 8 a.m.-1 p.m. will feature:
- A Keynote by Satish Jindal, Ph.D., CEO of Allied-Bristol Life Sciences (ABLS), a partnership between Bristol-Myers Squibb and Allied Minds. Using his extensive experience in forming and building biotechnology companies, Dr. Jindal will share anecdotal stories on ABLS’ unique innovator funding model.
- The U.S.-Israel R&D Fund (BIRD) will deliver a case study giving an overview of the Fund, as well as insights from Genewiz, one of its funding recipients.
- The NJ Health Foundation will deliver a case study featuring Actinobac, one of its portfolio companies.
- A Lunch Program featuring Brian Leuthner, President and CEO of Edge Therapeutics, just off a highly successful IPO, on the non-traditional path that Edge took to raise money.
- The results from BioNJ’s Entrepreneurship Survey, including what has worked in the past and what it means for companies in the New Jersey ecosystem.
- Networking. Networking. Networking.
The connections you’ll make and the unique insights you’ll gain will help guide and strengthen your business planning efforts.